Dr Lalchandani Labs Limited

DLCL6

INE871Z01013

Healthcare Facilities & Services

Delayed Bombay S.E. Other stock markets 06:01:00 2024-07-05 am EDT			5-day change	1st Jan Change
24.1 ^INR	+2.82%		+2.82%	+13.52%

May. 02	Dr Lalchandani Labs Limited Approves Appointment of Namita Anand as Company Secretary and Compliance Officer	CI
Apr. 06	Dr Lalchandani Labs Limited Announces Resignation of Karan Kumar as Company Secretary and Compliance Officer	CI

Dr Lalchandani Labs Limited Announces Executive Appointment

November 03, 2018 at 04:49 am EDT

Dr Lalchandani Labs Limited appointed Prakash Jhuraney as Independent Director and Mohit Lalchandani, Whole Time Director of the company as CEO at Annual General Meeting held on 2 November, 2018.

Latest news about Dr Lalchandani Labs Limited

Dr Lalchandani Labs Limited Approves Appointment of Namita Anand as Company Secretary and Compliance Officer	May. 02	CI
Dr Lalchandani Labs Limited Announces Resignation of Karan Kumar as Company Secretary and Compliance Officer	Apr. 06	CI
Dr Lalchandani Labs Limited Announces the Resignation of Archana R Jha as Company Secretary and Compliance Officer	Feb. 03	CI
Dr Lalchandani Labs Limited Approves Resignation of Monika Joshi as Company Secretary and Compliance Officer	Nov. 27	CI
Dr Lalchandani Labs Limited Reports Earnings Results for the Half Year Ended September 30, 2023	Nov. 14	CI
Dr Lalchandani Labs Limited Announces Resignation of Archana Jha from the Office of Company Secretary	23-09-23	CI
Dr Lalchandani Labs Limited Appoints Monika Joshi as Company Secretary and Compliance Officer, Effective August 27, 2023	23-08-25	CI
Dr Lalchandani Labs Limited Announces Resignation of Archana R Jha as Company Secretary	23-06-19	CI
Dr Lalchandani Labs Limited Reports Earnings Results for the Full Year Ended March 31, 2023	23-06-19	CI
Dr Lalchandani Labs Limited Announces Management Changes	23-02-16	CI
Dr Lalchandani Labs Limited Appoints Archana Jha as Company Secretary & Compliance Officer	23-02-05	CI
Dr Lalchandani Labs Limited Reports Earnings Results for the Half Year Ended September 30, 2022	22-11-14	CI
Dr Lalchandani Labs Limited Announces Resignation of CS Swati Poddar as Company Secretary and Compliance Officer	22-08-09	CI
Dr Lalchandani Labs Limited Resumes in Full Capacity At the Lab in Punjabi Bagh	22-05-30	CI
Dr Lalchandani Labs Limited Reports Earnings Results for the Full Year Ended March 31, 2022	22-05-30	CI
Dr Lalchandani Labs to Provide Diagnostic Services in Delhi, India, as Part of New Deal	22-03-21	MT
Dr Lalchandani Labs Limited Appoints Swati Chandra as Additional Director	22-03-09	CI
Dr Lalchandani Labs Limited Announces Resignation of Ms. Manica Gupta as Non-Executive Director	21-12-15	CI
Dr Lalchandani Labs Limited Reports Earnings Results for the Half Year Ended September 30, 2021	21-11-12	CI
Dr Lalchandani Labs' : Net Profit Soars in Fiscal Q4	21-07-12	MT
Dr Lalchandani Labs Limited Reports Earnings Results for the Full Year Ended March 31, 2021	21-07-12	CI
880,000 Equity Shares of Dr Lalchandani Labs Limited are subject to a Lock-Up Agreement Ending on 9-MAY-2021.	21-05-08	CI
Dr Lalchandani Labs : Gets Approval to be Listed as COVID-19 Vaccination Center	21-03-08	MT
Dr Lalchandani Labs Limited Announces Unaudited Earnings Results for the Half Year Ended September 30, 2020	20-11-13	CI
Dr Lalchandani Labs Limited Announces Increase in Capacity for Covid-19 RT-PCR Testing	20-09-28	CI

Chart Dr Lalchandani Labs Limited

Duration

Period

More charts

Dr Lalchandani Labs Limited is an India-based company, which is a provider of diagnostic and related healthcare tests and services in Delhi/NCR. The Company is engaged in the business of running laboratories for carrying out pathological investigations of various branches of biochemistry, hematology, histopathology, microbiology, electrophoresis, immunology, virology, cytology, and other pathological and radiological investigations. Through its integrated network, the Company offers patients and healthcare providers a range of diagnostic and related healthcare tests and services for use in core testing, patient diagnosis and the prevention, monitoring and treatment of disease and other health conditions. The Company has its own blood banking services through its sister concern CPC blood bank. Its customers include individual patients, hospitals and other healthcare providers and corporate customers.

Sector

Healthcare Facilities & Services

Calendar

2024-11-10 - Q2 2025 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Medical & Diagnostic Laboratories

	1st Jan change	Capi.
DR LALCHANDANI LABS LIMITED	+13.52%	1.25M
SONIC HEALTHCARE LIMITED	-17.92%	8.4B
RADNET, INC.	+72.10%	4.42B
DR. LAL PATHLABS LIMITED	+14.06%	2.94B
SYNLAB AG	-2.98%	2.65B
GUANGZHOU KINGMED DIAGNOSTICS GROUP CO., LTD.	-54.55%	1.82B
NEOGENOMICS, INC.	-11.31%	1.83B
FLEURY S.A.	-13.41%	1.57B
METROPOLIS HEALTHCARE LIMITED	+22.65%	1.26B
DIAN DIAGNOSTICS GROUP CO.,LTD.	-46.45%	1.09B